THANOCRINE
Dead / Abandoned — Abandoned — no statement of use filed (as of 30 Jan 2023)
What this means for you
This application is over — abandoned 30 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90379452
- Mark type
- Stylized text
- Filed
- 14 Dec 2020
- Published for opposition
- 02 Nov 2021
- Abandoned
- 30 Jan 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others
Owner
- SONATA THERAPEUTICS, INC., CAMBRIDGE, MA, US
- Inzen Therapeutics, Inc., Cambridge, MA, US
- Inzen Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 30 Jan 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Jan 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Jan 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jun 2022 — SOU EXTENSION 1 GRANTED
- 22 Jun 2022 — SOU EXTENSION 1 FILED
- 22 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 28 Dec 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Nov 2021 — PUBLISHED FOR OPPOSITION
- 13 Oct 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Sept 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Sept 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Sept 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Sept 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED